FDA Grants Accelerated Approval for ELREXFIO™ (elranatamab-bcmm) for Heavily Pre-treated Multiple Myeloma Patients (https://www.myeloma.org/news-events/multiple-myeloma-news/fda-accelerated-approval-elrexfio-elranatamab-bcmm)